Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Solidified Reverse Micellar Solution (SRMS)-Based Indomethacin Sustained-Release Tablets: Formulation and In vitro Evaluation

Salome A Chime¹ , Ikechukwu V Onyishi¹, Godswill C Onunkwo¹, Anthony A Attama²

¹Department of Pharmaceutical Technology and Industrial Pharmacy; ²Department of Pharmaceutics, University of Nigeria, Nsukka 410001, Nigeria.

For correspondence:- Salome Chime Email: emmymarachi@yahoo.com Tel:+2348061329790

Received: 22 September 2012 Accepted: 15 December 2013 Published: 20 February 2014

Citation: Chime SA, Onyishi IV, Onunkwo GC, Attama AA. Solidified Reverse Micellar Solution (SRMS)-Based Indomethacin Sustained-Release Tablets: Formulation and In vitro Evaluation. Trop J Pharm Res 2014; 13(2):211-216 doi: 10.4314/tjpr.v13i2.7

© 2014 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To formulate and evaluate sustained-release indomethacin tablets based on solidified reverse micellar solution (SRMS).

Methods: SRMS consisting of mixtures of phospholipid (Phospholipon^® 90H) and triglyceride (Softisan^® 154) were prepared in the ratios of 1:1, 2:1 and 1:2, respectively. SRMS-based tablets containing 75 mg of indomethacin each were prepared using a validated plastic mould. The physicochemical properties of the tablet formulations were studied. In vitro release study was carried out in simulated intestinal fluid (SIF, pH 7.5).

Results: The results showed that the physicochemical properties of the tablet formulations were significantly affected by the composition/ratio of the lipid matrix used (p < 0.05). Tablet hardness ranged from 5.00 ± 0.39 to 5.60 ± 0.36 kgf for tablets formulated with SRMS 1:2 and 2:1 (N₃ and N₂), respectively. The tablets exhibited friability of < 1 % (p < 0.05). Erosion time in SIF ranged from 124.0 ± 0.5 to 180.0 ± 1.1 min while drug release from the tablets reached a maximum in 8 – 11 h for all the batches.

Conclusion: Indomethacin tablets based on SRMS exhibited good sustained-release properties and can be further developed to achieve once daily administration for improved patient adherence to therapy.

Keywords: Solidified reverse micellar solution, Phospholipid, Triglyceride, Indomethacin, Sustained release